Appointment booking for Dr. Takashi Shinha, MD is currently not available.Dr. Takashi Shinha, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Takashi Shinha, MD (he/him) is a Infectious Disease Doctor in Honolulu, HI with over 11 years of experience. What is your opinion of Dr. Takashi Shinha, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 11 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Takashi Shinha, MD has received over $4,007 which includes payments from the following companies:
$803.71 from Insmed, Inc.
$481.45 from Allergan Inc.
$438.44 from Astellas Pharma US Inc
$370.37 from Merck Sharp & Dohme Corporation
$339.60 from Janssen Biotech, Inc.
$325.89 from Theravance Biopharma Inc.
$323.18 from Gilead Sciences Inc
$204.04 from Smith & Nephew, Inc.
$161.15 from Cumberland Pharmaceuticals, Inc.
$119.15 from Melinta Therapeutics, Inc.
$106.31 from ViiV Healthcare Company
$99.00 from Janssen Products, LP
$64.39 from The Medicines Company
$56.83 from EMD Serono, Inc.
$49.20 from Vyera Pharmaceuticals, LLC
$24.32 from Sanofi Pasteur Inc.
$15.41 from Beckman Coulter, Inc.
$13.54 from Paratek Pharmaceuticals, Inc.
$11.79 from Novo Nordisk Inc
Payments received by Dr. Takashi Shinha, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!